Integra LifeSciences Holdings (IART)
Quick ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | US$ in thousands | 246,375 | 215,157 | 215,236 | 591,906 | 276,402 | 273,732 | 309,192 | 307,367 | 456,661 | 511,937 | 447,152 | 407,092 | 513,448 | 470,231 | 397,414 | 408,976 | 470,166 | 396,279 | 360,981 | 357,712 |
Short-term investments | US$ in thousands | 27,192 | 62,441 | 81,691 | 71,194 | 32,694 | 19,938 | 20,200 | 15,659 | 0 | 13,111 | 4,369 | — | — | — | — | — | — | — | — | — |
Receivables | US$ in thousands | 272,370 | 248,298 | 271,155 | 241,092 | 259,327 | 256,270 | 258,663 | 253,995 | 263,465 | 248,268 | 237,361 | 234,010 | 231,831 | 222,232 | 229,823 | 223,542 | 225,532 | 218,184 | 179,143 | 245,546 |
Total current liabilities | US$ in thousands | 922,126 | 912,563 | 328,316 | 302,394 | 306,980 | 355,712 | 377,496 | 282,293 | 320,906 | 304,452 | 295,596 | 315,833 | 340,021 | 332,858 | 318,756 | 412,301 | 401,013 | 255,146 | 212,415 | 246,485 |
Quick ratio | 0.59 | 0.58 | 1.73 | 2.99 | 1.85 | 1.55 | 1.56 | 2.04 | 2.24 | 2.54 | 2.33 | 2.03 | 2.19 | 2.08 | 1.97 | 1.53 | 1.73 | 2.41 | 2.54 | 2.45 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($246,375K
+ $27,192K
+ $272,370K)
÷ $922,126K
= 0.59
The quick ratio of Integra LifeSciences Holdings has shown fluctuations over the period ranging from March 31, 2020, to December 31, 2024. The quick ratio, which measures the company's ability to meet its short-term obligations with its most liquid assets, was relatively stable between March 2020 and June 2022, ranging between 1.73 and 2.54.
However, there was a noticeable decrease in the quick ratio from December 31, 2022, to September 30, 2024, with the ratio dropping to as low as 0.58 and 0.59. This significant decline suggests a potential deterioration in the company's liquidity position during this period.
It is important to note that a quick ratio below 1 indicates that a company may struggle to meet its short-term obligations with its liquid assets alone, which could be a cause for concern for creditors and investors. Therefore, the downward trend in the quick ratio towards the end of the period under review may warrant further investigation into the company's liquidity management and financial health.
Peer comparison
Dec 31, 2024